Clinical Trial Update: Dimercaptosuccinic Acid (DMSA) Treatment of Children With Autism and Heavy Metal Toxicity [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial evaluated dimercaptosuccinic acid (DMSA) for autism in children with heavy metal toxicity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Heavy Metal Poisoning

Drugs mentioned

• DMSA (Dimercaptosuccinic acid)

Snippet

Sponsor: Southwest College of Naturopathic Medicine | Conditions: Autism | Phase 1, Phase 2 | Status: COMPLETED